ZUG, Switzerland--(BUSINESS WIRE)--PSI CRO, a global full-service contract research organization also known as the #AntibioticPowerhouse as pronounced by one of many of its infectious disease customers, announced today that they will be attending the upcoming ASM Microbe/ ICAAC (Interscience Conference on Antimicrobial Agents and Chemotherapy) in Boston, MA.
PSI will be represented at ASM Microbe/ ICAAC at Booth # 2211 beginning Friday, June 17th through Monday, June 20th at the Boston Convention & Exhibit Center.
PSI’s therapeutically aligned infectious diseases team that supports ID clinical trials at PSI will be in attendance. The team will include antimicrobial clinical trial experts and ID specialists from Medical Affairs & Project Management.
PSI continues to impact development of new antibiotics and speed up arrival of novel drugs to market through the successful management and on-time delivery of most complex global trials in the areas of CAP/HAP/VAP, cUTI, IAI, skin infections, sepsis, bacteremia and other infections. Case studies will be presented at the PSI booth by hands-on ID experts.
About PSI CRO:
PSI is a privately-owned, full-service contract research organization (CRO), operating globally. PSI’s reputation on the market place is that of a no-nonsense CRO, capable of saving pharmaceutical sponsors millions of development dollars by consistently meeting clinical trial timelines. PSI’s global reach supports the operations of clinical trials across multiple countries and continents. PSI is known to be highly selective about the work that they pursue. PSI has exceptionally high repeat and referral business rates, while maintaining minimal staff turnover indicative of its commitment to be the best CRO in the world as measured by its customers and its employees. Global headquarters are located in Zug (Zürich), Switzerland at 113a Baarerstrasse 6300. www.psi-cro.com